UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Population pharmacokinetic model of cefazolin in total hip arthroplasty

Scientific reports, 2021-10, Vol.11 (1), p.19763-19763, Article 19763

2021

Volltextzugriff (PDF)

Interindividual variability in dabigatran and rivaroxaban exposure: contribution of ABCB1 genetic polymorphisms and interaction with clarithromycin

Journal of thrombosis and haemostasis, 2017-02, Vol.15 (2), p.273-283

2017

Volltextzugriff (PDF)

Individualized PK‐based prophylaxis in severe haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-03, Vol.24 (S2), p.3-17

2018

Volltextzugriff (PDF)

Value of quantifying ABC transporters by mass spectrometry and impact on in vitro-to-in vivo prediction of transporter-mediated drug-drug interactions of rivaroxaban

European journal of pharmaceutics and biopharmaceutics, 2020-03, Vol.148, p.27-37

2020

Volltextzugriff (PDF)

Incidence and risk factors of major bleeding following major orthopaedic surgery with fondaparinux thromboprophylaxis. A time‐to‐event analysis

British journal of clinical pharmacology, 2018-10, Vol.84 (10), p.2242-2251

2018

Volltextzugriff (PDF)

AB0277 ASSOCIATION BETWEEN INTRA-ERYTHROCYTE METHOTREXATE POLYGLUTAMATE CONCENTRATION AND CLINICAL RESPONSE IN RHEUMATOID ARTHRITIS IN PATIENTS TREATED WITH METHOTREXATE INJECTABLE SUBCUTANEOUSLY

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.1164-1164

2021

Volltextzugriff (PDF)

Pharmacokinetic Model for Cefuroxime Dosing during Cardiac Surgery under Cardiopulmonary Bypass

Antimicrobial agents and chemotherapy, 2020-11, Vol.64 (12)

2020

Volltextzugriff (PDF)

Pharmacokinetic/pharmacodynamic model for unfractionated heparin dosing during cardiopulmonary bypass

British journal of anaesthesia : BJA, 2017-05, Vol.118 (5), p.705-712

2017

Volltextzugriff (PDF)

Immunosuppression with a subconjunctival implant releasing dexamethasone in a rabbit model of penetrating keratoplasty

Acta ophthalmologica (Oxford, England), 2016-10, Vol.94 (S256), p.n/a

2016

Volltextzugriff (PDF)

Is there really a relationship between the plasma concentration of the active metabolite of clopidogrel and the results of platelet function tests?

Journal of thrombosis and haemostasis, 2010-10, Vol.8 (10), p.2334-2338

2010

Volltextzugriff (PDF)

Antipsychotics: a real or confounding risk factor for venous thromboembolism?

Pharmacopsychiatry, 2013-01, Vol.46 (1), p.36-37

2013

Volltextzugriff (PDF)

Potential usefulness of activated charcoal (DOAC remove®) for dRVVT testing in patients receiving Direct Oral AntiCoagulants

Thrombosis research, 2019-12, Vol.184, p.86-91

2019

Volltextzugriff (PDF)

Investigation of PK-PD drug-drug interaction between acenocoumarol and amoxicillin plus clavulanic acid

Fundamental & clinical pharmacology, 2009-02, Vol.23 (1), p.127-135

2009

Volltextzugriff (PDF)

Le poids comme limite à l’utilisation des méthotrexate-polyglutamates pour l’évaluation de la réponse au traitement dans la polyarthrite rhumatoïde

Revue du rhumatisme (Ed. française : 1993), 2023-12, Vol.90, p.A146-A147

2023

Volltextzugriff (PDF)

Absence d’association entre la concentration du polyglutamate intra-érythrocytaire du méthotrexate et la réponse clinique au cours de la polyarthrite rhumatoïde (étude POLYGLU)

Revue du rhumatisme (Ed. française : 1993), 2021-12, Vol.88, p.A126-A127

2021

Volltextzugriff (PDF)

Étude des interactions médicamenteuses entre anticoagulants oraux directs et inhibiteurs de la phosphodiestérase de type-5 : y-a-t-il un risque pour les patients atteints d’hypertension artérielle pulmonaire ?

Revue des maladies respiratoires, 2018-01, Vol.35, p.A148-A149

2018

Volltextzugriff (PDF)

Proteomic biomarkers for survival in systemic sclerosis-associated pulmonary hypertension

Revue des maladies respiratoires actualités, 2024-01, Vol.16 (1), p.52

2024

Volltextzugriff (PDF)

PB0480 Tinzaparin Safety in Patients with Severe Renal Impairment

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.101907, Article 101907

2023

Volltextzugriff (PDF)

Risk of Direct Oral Anticoagulant Bioaccumulation in Patients with Pulmonary Hypertension

Respiration, 2016-01, Vol.91 (4), p.307-315

2016

Volltextzugriff (PDF)

Venovenous haemodiafiltration for the management of dabigatran overdose in intensive care unit

Clinical kidney journal, 2015-04, Vol.8 (2), p.199-201

2015

Volltextzugriff (PDF)

Population pharmacokinetics of fondaparinux administered at prophylactic doses after major orthopaedic surgery in everyday practice

Thrombosis and haemostasis, 2010-08, Vol.104 (2), p.252-260

2010

Volltextzugriff (PDF)

Intérêt de l’hémodiafiltration dans l’épuration du dabigatran : cas clinique

Néphrologie & thérapeutique, 2013-09, Vol.9 (5), p.318-319

2013

Volltextzugriff (PDF)

Pharmacokinetics of fondaparinux 1.5 mg once daily in a real-world cohort of patients with renal impairment undergoing major orthopaedic surgery

European journal of clinical pharmacology, 2012-10, Vol.68 (10), p.1403-1410

2012

Volltextzugriff (PDF)

MYCOPHENOLATE SODIUM DOSING IN COMBINATION WITH TACROLIMUS: PHARMACOKINETIC EVALUATION OF A NOVEL REGIMEN IN DE NOVO KINEY TRANSPLANT PATIENTS: 665

Transplantation, 2010-07, Vol.90, p.605

2010

Volltextzugriff (PDF)

Traitements anticoagulants et risques d’interactions médicamenteuses chez les patients traités pour hypertension pulmonaire

Revue des maladies respiratoires, 2014-01, Vol.31, p.A24-A24

2014

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(27)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(16)
Life Sciences & Biomedicine
(15)
Humans
(13)
Male
(11)
Adult
(8)
Female
(8)
Life Sciences
(6)
Pharmacology & Pharmacy
(6)
Aged
(5)
Aged, 80 And Over
(5)
Anticoagulants - Pharmacokinetics
(5)
Body Weight
(5)
Hematology
(5)
Middle Aged
(5)
Pharmacokinetics
(5)
Anticoagulants
(4)
Anticoagulants - Administration & Dosage
(4)
Cardiovascular System & Cardiology
(4)
Peripheral Vascular Disease
(4)
Prospective Studies
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Population pharmacokinetic model of cefazolin in total hip arthroplasty

Interindividual variability in dabigatran and rivaroxaban exposure: contribution of ABCB1 genetic polymorphisms and interaction with clarithromycin

Individualized PK‐based prophylaxis in severe haemophilia

Value of quantifying ABC transporters by mass spectrometry and impact on in vitro-to-in vivo prediction of transporter-mediated drug-drug interactions of rivaroxaban

Incidence and risk factors of major bleeding following major orthopaedic surgery with fondaparinux thromboprophylaxis. A time‐to‐event analysis

AB0277 ASSOCIATION BETWEEN INTRA-ERYTHROCYTE METHOTREXATE POLYGLUTAMATE CONCENTRATION AND CLINICAL RESPONSE IN RHEUMATOID ARTHRITIS IN PATIENTS TREATED WITH METHOTREXATE INJECTABLE SUBCUTANEOUSLY

Pharmacokinetic Model for Cefuroxime Dosing during Cardiac Surgery under Cardiopulmonary Bypass

Pharmacokinetic/pharmacodynamic model for unfractionated heparin dosing during cardiopulmonary bypass

Immunosuppression with a subconjunctival implant releasing dexamethasone in a rabbit model of penetrating keratoplasty

Is there really a relationship between the plasma concentration of the active metabolite of clopidogrel and the results of platelet function tests?

Antipsychotics: a real or confounding risk factor for venous thromboembolism?

Potential usefulness of activated charcoal (DOAC remove®) for dRVVT testing in patients receiving Direct Oral AntiCoagulants

Investigation of PK-PD drug-drug interaction between acenocoumarol and amoxicillin plus clavulanic acid

Le poids comme limite à l’utilisation des méthotrexate-polyglutamates pour l’évaluation de la réponse au traitement dans la polyarthrite rhumatoïde

Absence d’association entre la concentration du polyglutamate intra-érythrocytaire du méthotrexate et la réponse clinique au cours de la polyarthrite rhumatoïde (étude POLYGLU)

Étude des interactions médicamenteuses entre anticoagulants oraux directs et inhibiteurs de la phosphodiestérase de type-5 : y-a-t-il un risque pour les patients atteints d’hypertension artérielle pulmonaire ?

Proteomic biomarkers for survival in systemic sclerosis-associated pulmonary hypertension

PB0480 Tinzaparin Safety in Patients with Severe Renal Impairment

Risk of Direct Oral Anticoagulant Bioaccumulation in Patients with Pulmonary Hypertension

Venovenous haemodiafiltration for the management of dabigatran overdose in intensive care unit

Population pharmacokinetics of fondaparinux administered at prophylactic doses after major orthopaedic surgery in everyday practice

Intérêt de l’hémodiafiltration dans l’épuration du dabigatran : cas clinique

Pharmacokinetics of fondaparinux 1.5 mg once daily in a real-world cohort of patients with renal impairment undergoing major orthopaedic surgery

MYCOPHENOLATE SODIUM DOSING IN COMBINATION WITH TACROLIMUS: PHARMACOKINETIC EVALUATION OF A NOVEL REGIMEN IN DE NOVO KINEY TRANSPLANT PATIENTS: 665

Traitements anticoagulants et risques d’interactions médicamenteuses chez les patients traités pour hypertension pulmonaire

Suchergebnisse filtern